EGFR and head and neck squamous cell carcinoma: Previous studies have reported that cetuximab efficacy depends on the expression of the EGFR ligand (especially amphiregulin) in HNSCC, non-small cell lung cancer (NSCLC), and colorectal cancer (CRC)10,11.